Introduction
Hyaluronic acid (HA) plays a dual role in physiological processes. High-molecular-weight HA serves as a lubricant and anti-inflammatory agent, whereas its degradation by the enzyme hyaluronidase (HAase) into low-molecular-weight fragments (LMWHAs) triggers pro-inflammatory signaling. Excessive HA degradation is a hallmark of various inflammatory diseases. While natural pentacyclic triterpenoids like betulinic acid (BA) possess some HAase inhibitory potential, their natural potency is insufficient for therapeutic applications. This study explores the synthesis of BA derivatives modified with an $\alpha,\beta$-unsaturated ketene moiety to enhance their anti-inflammatory and HAase-inhibitory properties.
Methodology
The researchers synthesized two series of BA derivatives using Claisen-Schmidt condensation to introduce an $\alpha,\beta$-unsaturated ketene moiety at the C-3 position.
- Series 1: Retained the C-28 carboxylic acid group.
- Series 2: Converted the C-28 group into a methyl ester.
Biological evaluation involved in vitro enzymatic assays against HAase and cell-based models using BV2 (murine microglia), RAW264.7 (murine macrophages), and THP-1 (human monocytes). Inflammation was induced using either Lipopolysaccharide (LPS) or specific HA fragments to assess the compounds' ability to reduce nitric oxide (NO) and pro-inflammatory cytokines like IL-6.
Results and Key Insights
The structural modifications significantly enhanced biological activity. Series 1 derivatives showed substantial HAase inhibition, ranging from 26.3% to 72.8%, compared to only 22.6% for the parent BA compound. In contrast, Series 2 (methyl esters) exhibited negligible activity, highlighting the critical role of the C-28 free carboxylic acid for enzyme binding.
Compound BA-06 was identified as the most potent inhibitor with an $IC_{50}$ of 18.3 μM. Beyond enzymatic inhibition, these derivatives demonstrated robust anti-inflammatory effects. In BV2 and RAW264.7 cells, they reduced LPS-induced nitrite production by up to 46.8% and 49.2%, respectively. Crucially, the compounds also suppressed inflammation specifically induced by HA fragments in human THP-1 cells, reducing IL-6 secretion and NO production.
Molecular Docking and Binding Mechanism
Computational modeling provided a structural basis for the observed potency. Docking studies of the most active derivatives revealed that the $\alpha,\beta$-unsaturated ketene moiety facilitates deeper penetration into the HAase hydrophilic pocket. The C-28 carboxylic acid acts as a molecular "anchor," forming essential hydrogen bonds with amino acid residues such as Arg196, Arg240, and Arg20. This multi-point interaction stabilizes the inhibitor-enzyme complex, explaining the superior performance of Series 1 over the parent compound and the inactive methyl esters.
Conclusion and Future Directions
This study successfully demonstrates that targeted modification of the betulinic acid skeleton can yield potent hyaluronidase inhibitors with significant anti-inflammatory potential. While these in vitro results are promising, further research is needed to evaluate these compounds in in vivo models to assess metabolic stability and bioavailability. Additionally, given the molecular weight of these triterpenoids, their ability to cross the blood-brain barrier remains a challenge for treating neuroinflammatory conditions, necessitating future investigations into specialized drug delivery systems.
Summary updated